Divi`s Laboratories` Market Capitalization
| Case Code: FINC183 Case Length: 8 Pages Period: 2003-2021 Pub Date: 2021 Teaching Note: Available |
Price: Rs.200 Organization: Divis Laboratories Limited Industry: Pharmaceuticals & Biotech Countries: India Themes: Investment Decisions Investment Philosophy |
Abstract Case Intro 1 Case Intro 2 Excerpts
Introduction
On December 17, 2020, India-based pharmaceutical company Divi’s Laboratories Limited (Divi’s) entered the elite club of companies with a Rs. 1 trillion market capitalization in the Indian stock exchanges (BSE and NSE). Divi’s was the second Pharma company in India after Sun Pharmaceutical Industries (Sun) to across the Rs. 1 trillion benchmark . Sun was valued at around Rs.1.4 trillion in December 2020, and Divi’s was valued at Rs. 1.01 trillion on the December 17, 2020, with a market price of Rs. 3,847.90 per share, surpassing its previous highest price of Rs. 3,763.40 recorded on December 10, 2020. (Refer to Exhibit I for List of the Companies having Market Capitalization of above Rs. 1 Trillion in India)..
Buy this case study (Please select any one of the payment options)
| Price: Rs.200 |
Price: Rs.200 | PayPal (5 USD) |
